Inhibition of opiate tolerance by non-competitive N-d-aspartate receptor antagonists

[1]  G. Collingridge,et al.  The NMDA Receptor , 1995 .

[2]  K. A. Trujillo,et al.  MK-801 inhibits the development of morphine tolerance at spinal sites , 1993, Brain Research.

[3]  P. Tiseo,et al.  Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. , 1993, The Journal of pharmacology and experimental therapeutics.

[4]  Ronald Melzack,et al.  Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence , 1993, Pain.

[5]  T. Gordh,et al.  The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans , 1992, Pain.

[6]  G. Pasternak,et al.  NG-nitro-L-arginine prevents morphine tolerance. , 1992, European journal of pharmacology.

[7]  H. Akil,et al.  DOES MK-801 INHIBIT THE DEVELOPMENT OF MORPHINE TOLERANCE IN THE RAT AT SPINAL SITES? , 1992 .

[8]  H. Kalant,et al.  Ketamine retards chronic but not acute tolerance to ethanol , 1992, Pharmacology Biochemistry and Behavior.

[9]  C. Gambarana,et al.  NMDA receptor inhibition prevents tolerance to cocaine , 1992, Pharmacology Biochemistry and Behavior.

[10]  A. Vaccarino,et al.  The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat , 1992, Brain Research.

[11]  S. Mihic,et al.  Differential inhibition by NMDA antagonists of rapid tolerance to, and cross-tolerance between, ethanol and chlordiazepoxide , 1992, Brain Research.

[12]  M. Shoaib,et al.  MK801 attenuates behavioural adaptation to chronic nicotine administration in rats , 1992, British journal of pharmacology.

[13]  M. Wolf,et al.  Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine , 1991, Brain Research.

[14]  H. Akil,et al.  Opiate tolerance and dependence: recent findings and synthesis. , 1991, The New biologist.

[15]  J. Jaffe,et al.  Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan , 1991, Pharmacology Biochemistry and Behavior.

[16]  A. Vaccarino,et al.  Delayed application of MK-801 attenuates development of morphine tolerance in rats , 1991, Brain Research.

[17]  H. Cappell,et al.  Homeostatic theory of drug tolerance: a general model of physiological adaptation. , 1991, Psychological review.

[18]  M. Gold,et al.  Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat , 1991, Brain Research.

[19]  H. Kalant,et al.  NMDA antagonist inhibits rapid tolerance to ethanol , 1991, Brain Research Bulletin.

[20]  Clifford J. Woolf,et al.  The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states , 1991, Pain.

[21]  H. Akil,et al.  The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality , 1991, Pharmacology Biochemistry and Behavior.

[22]  S. Tiffany,et al.  Effect of interdose interval on the development of associative tolerance to morphine in the rat: a dose-response analysis. , 1991, Behavioral neuroscience.

[23]  H. Akil,et al.  Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. , 1991, Science.

[24]  S. A. Turkanis,et al.  Amphetamine behavioral sensitization and the excitatory amino acids , 1990, Brain Research.

[25]  W Singer,et al.  Excitatory amino acid receptors and synaptic plasticity. , 1990, Trends in pharmacological sciences.

[26]  D. Lodge,et al.  Noncompetitive excitatory amino acid receptor antagonists. , 1990, Trends in pharmacological sciences.

[27]  R. Dafters,et al.  Effects of dose, interdose interval, and drug-signal parameters on morphine analgesic tolerance: implications for current theories of tolerance. , 1989, Behavioral neuroscience.

[28]  S. Iversen,et al.  The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. , 1989, European journal of pharmacology.

[29]  G. Collingridge,et al.  Excitatory amino acid receptors in the vertebrate central nervous system. , 1989, Pharmacological reviews.

[30]  A. Vezzani,et al.  Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. , 1989, The Journal of pharmacology and experimental therapeutics.

[31]  D. Lodge,et al.  Phencyclidine receptors and N-methyl-D-aspartate antagonsim: Electrophysiologic data correlates with known behaviours , 1988, Pharmacology Biochemistry and Behavior.

[32]  S. Tiffany,et al.  Tolerance to morphine in the rat: associative and nonassociative effects. , 1988, Behavioral neuroscience.

[33]  J. Watkins,et al.  The pharmacological selectivity of three NMDA antagonists. , 1988, European journal of pharmacology.

[34]  E. Wong,et al.  [3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes , 1988, Journal of neurochemistry.

[35]  D. Lodge,et al.  Evidence for involvement ofN-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat , 1987, Brain Research.

[36]  A. Dickenson,et al.  Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following c fibre stimulation. , 1987, Neuropharmacology.

[37]  L. Iversen,et al.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Inturrisi,et al.  Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat. , 1985, The Journal of pharmacology and experimental therapeutics.

[39]  C. Advokat.  Environmental modulation of analgesic tolerance induced by morphine pellets , 1981, Pharmacology Biochemistry and Behavior.

[40]  C. Advokat.  Analgesic tolerance produced by morphine pellets is facilitated by analgesic testing , 1981, Pharmacology Biochemistry and Behavior.

[41]  A. Misra,et al.  Disposition of [3H] phencyclidine in the rat after single and multiple doses. , 1980, Life sciences.

[42]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .

[43]  S. A. Turkanis,et al.  Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. , 1989, Life sciences.

[44]  J. Miller,et al.  Associate and non-associative tolerance to morphine: support for a dual-process habituation model. , 1988, Life sciences.

[45]  T. Baker,et al.  Morphine tolerance as habituation. , 1985, Psychological review.

[46]  P. Soubrié,et al.  A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in mice , 1982 .

[47]  B. Clineschmidt,et al.  Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties , 1982 .